Schedule 13G ownership disclosure

AGILE THERAPEUTICS INC

Security class unavailable · CUSIP: 00847L100

Event date: 2018-05-16

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
6.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-18-176779
Form type
SC 13G
Filer
Oncternal Therapeutics, Inc.
CIK
CIK 1260990
Filed
May 29, 2018
Reporting period
May 16, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub